Mail

Italia markets closed

FTSE MIB
33.629,21
-107,19(-0,32%)
Dow Jones
38.675,68
+450,02(+1,18%)
Nasdaq
16.156,33
+315,37(+1,99%)
Nikkei 225
38.236,07
-37,98(-0,10%)
Petrolio
77,99
-0,96(-1,22%)
Bitcoin EUR
59.294,03
+1.838,96(+3,20%)

Arbutus Biopharma Corporation (ABUS)

NasdaqGS - NasdaqGS Prezzo in tempo reale. Valuta in USD.

Aggiungi a watchlist

2,7100

+0,0300

(+1,12%)

Alla chiusura: 04:00PM EDT

2,7000

-0,01

(-0,37%)

Dopo ore:

05:39PM EDT

Maggiori azionisti

Elenco insider

Transazioni interne

Elenco insider

Individuo o ente	Ultima transazione	Data	Azioni possedute alla data della transazione
ABRAMS MICHAEL J Officer	Conversion of Exercise of derivative security	15 ago 2016	42.097
COLLIER WILLIAM H. Chief Executive Officer	Stock Award(Grant)	31 gen 2023	216.500
HASTINGS DAVID C Chief Financial Officer	Sale	01 feb 2024	181.907
HOWARD ELIZABETH ANN Officer	Stock Award(Grant)	31 gen 2023	86.024
MC ELHAUGH MICHAEL JOHN Chief Executive Officer	Sale	01 feb 2024	1.504.790
MURRAY MARK J Director	Conversion of Exercise of derivative security	27 nov 2018	341.396
NAFTZGER J CHRISTOPHER General Counsel	Stock Award(Grant)	31 gen 2024	95.100
ROIVANT SCIENCES LTD. Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security	17 ott 2021	38.847.500
SIMS KAREN Officer	Sale	01 feb 2024	125.542
SOFIA MICHAEL JOSEPH Officer	Sale	01 feb 2024	1.652.280
*I dati sull'elenco interno provengono esclusivamente dai rapporti presentati alla SEC del modulo 3 e 4 degli ultimi 24 mesi.